530233 — Auro Laboratories Balance Sheet
0.000.00%
Last trade - 00:00- IN₹1.07bn
- IN₹1.24bn
- IN₹536.35m
- 62
- 51
- 69
- 68
Annual balance sheet for Auro Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 81.1 | 183 | 198 | 115 | 92.2 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 57.8 | 73 | 136 | 124 | 134 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 179 | 282 | 376 | 357 | 309 |
| Net Property, Plant And Equipment | 144 | 137 | 173 | 203 | 548 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 323 | 419 | 550 | 560 | 857 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 61.4 | 84.7 | 201 | 181 | 239 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 109 | 133 | 234 | 218 | 438 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 215 | 286 | 315 | 342 | 420 |
| Total Liabilities & Shareholders' Equity | 323 | 419 | 550 | 560 | 857 |
| Total Common Shares Outstanding |